Drugs / Control
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06253650 | Mar 2024 → Mar 2027 expected | gastric cancer | Gruppo Oncologico del Nord-Ovest | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Control | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06253650 ↗ |
| Route | Intravenous | “5-fluorouracil 2600 mg/m2 continuous intravenous infusion day 1 for 24 hours every 2 weeks” NCT06253650 ↗ |